During the Well Characterized Biologics and Biological Assays Conference 2022 (November 1-3) connect with our Intertek team to explore how we can help you accelerate your biologic development programs.
This leading biologics and biological assays event brings together industry leaders - sharing best practices for accelerating development of novel biologics therapeutics and complex molecules towards CMC success.
Visit our booth to discuss how our expertise across biopharmaceutical development support can accelerate your program milestones or contact us now to arrange a meeting during the event.
November 1-3, 2022
College Park Marriott Hotel & Conference Center,
Hyattsville, Maryland, USA
2022 WELL CHARACTERIZED BIOLOGICS & BIOLOGICAL ASSAYS: PRESENTATION
This year, Intertek technical expert, Michael Walker, will be presenting live on stage - you won't want to miss it!
TALK: Characterisation of Disulphide Bond Status for Biotherapeutic Proteins
SPEAKER: Michael Walker, Technical Expert LC-MS Protein Analysis, Intertek Pharmaceutical Services
GET YOUR COPY: You can request the presentation slides here. We’d be happy to send them after the event.
2021 WELL CHARACTERIZED BIOLOGICS & BIOLOGICAL ASSAYS: PRESENTATION
During last year's Well Characterized Biologic & Biological Assays conference, our expert, Ashleigh Wake, highlighted the most important considerations for development of inhaled or intranasal biologics.
TALK: Top Considerations for the Development of Inhaled Biologics
SPEAKER: Ashleigh Wake, Business Development Director, Intertek Pharmaceutical Services
WATCH NOW: Missed our presentation on Top Considerations for the Development of Inhaled Biologics? You can watch it on-demand now.
- WHITE PAPER: Biophysical Characterisation of Tocilizumab
- WHITE PAPER: Monitoring of Glycosylation Analytical Approaches for Antibody-Based Therapeutics
- WHITE PAPER: Characterization of Bispecifics
- ARTICLE: Monoclonal Antibody Structural Characterization Challenges
- ARTICLE: Physicochemical Properties of Liposomal Advanced Drug Delivery Technologies
About Intertek
For nearly 30 years we have helped the world’s most innovative pharmaceutical and biopharmaceutical companies to navigate the challenges of new product development, drug delivery, production and market release. We provide a broad range of cGMP, GLP, GCP laboratory services, across many product types such as proteins, mAb, bispecifics, peptides, vaccines, oligonucleotides, mRNA and more.
At Intertek, we apply our experience, industry, and regulatory knowledge to design phase specific analytical development programs, tailored to your needs throughout the product lifecycle. We focus on monitoring relevant critical quality attributes (CQAs), to evaluate the impact of process changes on physicochemical properties and structure according to ICH Q6B. We determine product related impurities or process-related impurities and conduct stability studies. We also help you to demonstrate consistency or comparability of manufactured batches and conduct release tests for clinical trial materials or ongoing production.
Related Links
Pharmaceutical News & Events
- Determination of Particles in Pharmaceuticals - Article
- Discover our Audit Live Tool for direct access to our scheduled audits
- Extractables/Leachables Lab Tour - Request access
- Medical Device Extractables & Leachables Studies
- Glycosylation Analytical Approaches for Antibody Therapeutics
- Rapid Determination of Low/Trace Level Benzene in Pharmaceutical Excipients and Finished Products
- mRNA Analytics: Capping Efficiency, Sequencing, Poly-A Tail, dsRNA
Intertek Pharmaceutical Services Manchester
P.O. Box 42
Hexagon Tower
Blackley
Manchester, M9 8ZS
United Kingdom
For location use: M9 8GQ
